Liao, David S <br/><br/>
Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial.  [electronic resource] 

 -  Ophthalmology  02 2020 
 - 186-195 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1549-4713 
<br/><br/><label>Standard No.: </label>10.1016/j.ophtha.2019.07.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Complement C3--antagonists & inhibitors<br/>Complement Inactivating Agents--therapeutic use<br/>Female<br/>Fluorescein Angiography<br/>Geographic Atrophy--diagnosis<br/>Humans<br/>Intravitreal Injections<br/>Macular Degeneration--complications<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Tomography, Optical Coherence<br/>Visual Acuity--physiology